ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,668.92
      1.34%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Centogene NV (CNTG)

      7. Centogene NV (CNTG) News

      CNTG

      Centogene NV (CNTG)

      Centogene NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CNTG
      DateTimeSourceHeadlineSymbolCompany
      06/30/20234:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTGCentogene NV
      06/30/20234:30PMGlobeNewswire Inc.CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General MeetingNASDAQ:CNTGCentogene NV
      06/27/20239:37AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      06/27/20237:30AMGlobeNewswire Inc.CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million InvestmentNASDAQ:CNTGCentogene NV
      06/14/20234:30PMGlobeNewswire Inc.CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencyNASDAQ:CNTGCentogene NV
      06/13/202310:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      05/19/20239:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      05/17/20236:01AMEdgar (US Regulatory)Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)NASDAQ:CNTGCentogene NV
      05/17/20236:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      05/16/20236:25PMGlobeNewswire Inc.CENTOGENE Reports Full Year 2022 Financial ResultsNASDAQ:CNTGCentogene NV
      05/05/20236:30AMGlobeNewswire Inc.CENTOGENE to Participate in Upcoming Conferences in MayNASDAQ:CNTGCentogene NV
      05/04/20234:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      04/28/20237:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      04/28/20236:30AMGlobeNewswire Inc.CENTOGENE Receives Nasdaq Non-Compliance NoticeNASDAQ:CNTGCentogene NV
      04/26/20238:30AMGlobeNewswire Inc.CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics PipelineNASDAQ:CNTGCentogene NV
      04/26/20238:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      04/14/20238:00AMGlobeNewswire Inc.CENTOGENE to Participate in Upcoming Conferences in AprilNASDAQ:CNTGCentogene NV
      04/12/20236:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      04/12/20236:30AMGlobeNewswire Inc.CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative DiseasesNASDAQ:CNTGCentogene NV
      04/11/20237:20AMDow Jones NewsCentogene Extends Genetic Testing Partnership With TakedaNASDAQ:CNTGCentogene NV
      04/11/20236:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      04/11/20236:30AMGlobeNewswire Inc.CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersNASDAQ:CNTGCentogene NV
      03/28/20236:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      03/14/20238:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      03/09/20236:30AMGlobeNewswire Inc.CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - PharmaNASDAQ:CNTGCentogene NV
      03/08/20236:30AMGlobeNewswire Inc.CENTOGENE to Participate in Upcoming Conferences in MarchNASDAQ:CNTGCentogene NV
      02/21/20236:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      02/21/20236:30AMGlobeNewswire Inc.In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)NASDAQ:CNTGCentogene NV
      02/07/20238:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTGCentogene NV
      02/07/20238:00AMGlobeNewswire Inc.CENTOGENE Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CNTGCentogene NV
       Showing the most relevant articles for your search:NASDAQ:CNTG